Abstract

Mantle cell lymphoma(MCL)is a group of highly aggressive non-Hodgkin lymphoma(NHL)in small B-cell lymphoma, accounting for 6 % of NHL incidence. MCL is characterized with its concealed onset, strong aggression, high malignancy and poor prognosis. Therefore, more attention should be paid to the diagnosis and differential diagnosis of MCL in clinic. Recently, diagnostic models of molecular pathology, researches on cyclin D1 protein negative MCL, staging prognosis and stratification treatment of MCL are worthy of attention. Key words: Lymphoma, mantle cell; Lymphoma, non-Hodgkin; Diagnosis; Treatment

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call